Clinical Trials Directory

Trials / Completed

CompletedNCT03140748

Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with therapeutic success. On the other hand, there are no data on intraabdominal infections that are much more frequent. The objective of the study is to evaluate the initial levels of β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation compared to a control group with a yeast-free peritonitis.

Conditions

Interventions

TypeNameDescription
OTHERTo evaluate the initial levels and kinetics of serum β-D-glucanTo evaluate the initial levels and kinetics of serum β-D-glucan during fungal peritonitis compared to a control group of yeast-free peritonitis

Timeline

Start date
2018-05-01
Primary completion
2021-08-22
Completion
2023-06-01
First posted
2017-05-04
Last updated
2025-09-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03140748. Inclusion in this directory is not an endorsement.

Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation (NCT03140748) · Clinical Trials Directory